Stock listing
COCP Stock Price, News, Filings & Events — Cocrystal Pharma, Inc.
Selected listing: COCP · NASDAQ · USD · US
This page tracks Cocrystal Pharma, Inc.'s COCP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COCP:NASDAQ. COCP:NASDAQ is the stock-level entry point for investors researching Cocrystal Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cocrystal Pharma, Inc. is a public company traded on the American stock market under the ticker COCP. The company has a market capitalization of approximately $12.4 million. Cocrystal Pharma focuses on developing antiviral therapeutics for various diseases.

- Ticker
- COCP:NASDAQ
- Asset type
- Stock
- Market cap
- $15.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Cocrystal Pharma, Inc. COCP:NASDAQ stock context
This page tracks Cocrystal Pharma, Inc.'s COCP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COCP:NASDAQ. COCP:NASDAQ is the stock-level entry point for investors researching Cocrystal Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cocrystal Pharma, Inc. is a public company traded on the American stock market under the ticker COCP. The company has a market capitalization of approximately $12.4 million. Cocrystal Pharma focuses on developing antiviral therapeutics for various diseases.
Research Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. investor report
Review AI stock analysis and investor report context for COCP:NASDAQ.
Cocrystal Pharma, Inc. company profile
View the public company page for Cocrystal Pharma, Inc. on 6ix.
Cocrystal Pharma, Inc. news
Read company news and market updates connected to Cocrystal Pharma, Inc..
Cocrystal Pharma, Inc. investor events
Find investor webinars, events, and replay context for Cocrystal Pharma, Inc..
Alternate listings
8CC:TRADEGATE
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
A3DWYX:LS
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
A3DWYX:LSX
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
8CC:GETTEX
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
COCP:BOATS
US · USD
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
8CC:DUS
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
8CC:FWB
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
8CC:MUN
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.
8CC:SWB
DE · EUR
Alternate listing for Cocrystal Pharma, Inc.; the primary context on this page is COCP:NASDAQ.